Table 3.
Summary of the use of functionalized MNPs for AMF- or NIR-laser-induced cancer therapy.
| Types of MNPs | Functionalizing Agents | Cancer Cells | Type of Study | AMF | NIR Light | Reference | |
|---|---|---|---|---|---|---|---|
| Wavelength (nm) | Intensity (W cm−2) | ||||||
| Fe3O4 nanocubes | - | SKOV3, PC3, A431 | In vitro, in vivo | 110 kHz | 808 | 0.3 | [12] |
| Citric-acid-capped Fe3O4 | Cationic liposome | U87MG | In vitro | 52 kHz | 808 | 1.8 | [130] |
| Fe3O4 | Poly-acrylic acid, lactoferrin, DOX | 4T1 | In vitro, in vivo | 540 kHz | 808 | 5 | [131] |
| Fe3O4@Au (core–shell) | CET | U251 | In vitro, in vivo | 230 kHz | 635 | 0.3 | [132] |